The human disease gene LYSET is essential for lysosomal enzyme transport and viral infection.

Authors:
Christopher M Richards, Sabrina Jabs, Wenjie Qiao, Lauren D Varanese, Michaela Schweizer, Peter R Mosen, Nicholas M Riley, Malte Klüssendorf, James R Zengel, Ryan A Flynn, Arjun Rustagi, John C Widen, Christine E Peters, Yaw Shin Ooi, Xuping Xie, Pei-Yong Shi, Ralf Bartenschlager, Andreas S Puschnik, Matthew Bogyo, Carolyn R Bertozzi, Catherine A Blish, Dominic Winter, Claude M Nagamine, Thomas Braulke, Jan E Carette
Year of publication:
2022
Volume:
-
Issue:
-
Issn:
0036-8075
Journal title abbreviated:
SCIENCE
Journal title long:
Science : a weekly journal devoted to the advancement of science / American Association for the Advancement of Science
Impact factor:
47.728
Abstract:
Lysosomes are key degradative compartments of the cell. Transport to lysosomes relies on GlcNAc-1-phosphotransferase-mediated tagging of soluble enzymes with mannose 6-phosphate (M6P). GlcNAc-1-phosphotransferase deficiency leads to the severe lysosomal storage disorder mucolipidosis II (MLII). Several viruses require lysosomal cathepsins to cleave structural proteins and thus depend on functional GlcNAc-1-phosphotransferase. Here, we used genome-scale CRISPR screens to identify Lysosomal Enzyme Trafficking factor (LYSET) as essential for infection by cathepsin-dependent viruses including SARS-CoV-2. LYSET deficiency resulted in global loss of M6P tagging and mislocalization of GlcNAc-1-phosphotransferase from the Golgi complex to lysosomes. Lyset knockout mice exhibited MLII-like phenotypes and human pathogenic LYSET alleles failed to restore lysosomal sorting defects. Thus, LYSET is required for correct functioning of the M6P trafficking machinery, and mutations in LYSET can explain the phenotype of the associated disorder.